People · Operator
Named in public records as an officer, director or promoter · active 2008–2026 · Biotechnology, Other Technology, Software / Tech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| uLab Systems, Inc. | — | Biotechnology | Series C | $90.9M | $2.8B | 2021 |
| Sonitus Medical Inc | — | Other Technology | Series B | $57.6M | $311.1M | 2009 |
| Tusker Medical, Inc. | — | Biotechnology | Series B | $53.5M | $79.4M | 2016 |
| Ventaris Surgical, Inc. | — | Biotechnology | Series B | $30.7M | $114.2M | 2026 |
| BRIUS Technologies, Inc. | — | Software / Tech | Series B | $21.2M | $110.0M | 2025 |
| Sonitus Technologies Inc. | — | Software / Tech | Series A | $17.1M | $11.7M | 2014 |
| Rodo Medical, Inc. | — | Other Technology | Series A | $7.7M | $15.8M | 2014 |
| NextBio | — | Other | Series A | $6.8M | $102.3M | 2008 |
Amir Abolfathi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Amir Abolfathi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Arman Pahlavan | 3 | 12 |
| Sami Hamade | 3 | 6 |
| Greg Garfield | 2 | 8 |
| Mark Foley | 2 | 5 |
| Seth Harrison | 1 | 19 |
| Carter Meyer | 1 | 14 |
| Nael Kassar | 1 | 11 |
| Frederic Moll | 1 | 10 |
| Mostafa Ronaghi | 1 | 8 |
| David Barker | 1 | 7 |
| Renee Ryan | 1 | 6 |
| Patrick Rivelli | 1 | 6 |
| Justin Klein | 1 | 6 |
| Kevin Mosher | 1 | 6 |
| David Thrower | 1 | 5 |
| David McIntyre | 1 | 5 |
| Varun Gupta | 1 | 4 |
| Karen Long | 1 | 4 |
| Saeid Akhtari | 1 | 3 |
| Shahram Seyedin-Noor | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.